Rosmarinic Acid, a Bioactive Phenolic Compound, Inhibits Glutamate Release from Rat Cerebrocortical Synaptosomes through GABA A Receptor Activation

Rosmarinic Acid, a Bioactive Phenolic Compound, Inhibits Glutamate Release from Rat Cerebrocortical Synaptosomes through GABA A Receptor Activation

Rosmarinic acid, a serious part of rosemary, is a polyphenolic compound with potential neuroprotective results. Asreducing the synaptic launch of glutamate is essential to reaching neuroprotectant’s pharmacotherapeutic results, the impact of rosmarinic acid on glutamate launch was investigated in rat cerebrocortical nerve terminals (synaptosomes). Rosmarinic acid depressed the 4-aminopyridine (4-AP)-induced glutamate launch in a concentration-dependent method. The removing of extracellular calcium and the blockade of vesicular transporters prevented the inhibition of glutamate launch by rosmarinic acid.

Rosmarinic acid decreased 4-AP-induced intrasynaptosomal Ca2+ elevation. The inhibition of N-, P/Q-type Ca2+ channels and the calcium/calmodulin-dependent kinase II (CaMKII) prevented rosmarinic acid from having results on glutamate launch. Rosmarinic acid additionally decreased the 4-AP-induced activation of CaMKII and the next phosphorylation of synapsin I, the primary presynaptic goal of CaMKII. As well as, immunocytochemistry confirmed the presence of GABAA receptors. GABAA receptor agonist and antagonist blocked the inhibitory impact of rosmarinic acid on 4-AP-evoked glutamate launch.

Docking knowledge additionally revealed that rosmarinic acid shaped a hydrogen bond with the amino acid residues of GABAA receptor. These outcomes instructed that rosmarinic acid prompts GABAA receptors in cerebrocortical synaptosomes to lower Ca2+ inflow and CaMKII/synapsin I pathway to inhibit the evoked glutamate launch.

Encapsulation of bioactive compounds from byproducts of two species of passionflowers: analysis of the physicochemical properties and managed launch in a gastrointestinal mannequin

This examine aimed to guage the discharge of energetic parts with antioxidant and antihypertensive capability from encapsulated extracts of the peel and seeds of Gulupa (Passiflora edulis f. edulis) and Cholupa (Passiflora maliformis) in an in vitro gastrointestinal digestion mannequin. Microencapsulated extracts have been ready with enzymatically modified rice starch because the encapsulating materials and ethanol extracts of seeds and peel of P. edulis f. edulis and P. maliformis as encapsulated materials. Microcapsule characterization was carried out by scanning electron microscopy with values of 4.54-5.13 μm and ξ potential values of -6.34 mV and -6.66 mV.

Dynamic gentle scattering (DLS) evaluation was performed with polydispersion values from 1.33 to 1.51, and dispersion stability evaluation was additionally performed. The overall phenol content material and antioxidant actions (ABTS, DPPH, and FRAP) and ACE inhibitory exercise (in vitro antihypertensive exercise) have been evaluated after every stage of digestion, with values higher than 80% of exercise earlier than gastrointestinal transit and with values higher than 55% exercise after the top of gastrointestinal transit. Gastrointestinal analysis of the encapsulated extracts was carried out with an ex vivo mannequin utilizing pig intestines and simulating the circumstances of digestion in three phases: the gastric (pH 2.Zero with 1.

Zero M HCl +0.5 g/L pepsin), enteric (pH 8.Zero with Krebs resolution +1.Zero mL/L bile) and last enteric (pH 7.5 Krebs resolution solely) phases. The microencapsulation of passionflower extracts confirmed good conduct in opposition to adjustments in pH and enzymatic actions all through digestion, thus selling a managed launch and focused supply of bioactive compounds, present process a paracellular mechanism by means of the intestinal barrier to protect the antioxidant exercise and ACE inhibitory that was proven by the extracts earlier than encapsulation of the fabric.

Rosmarinic Acid, a Bioactive Phenolic Compound, Inhibits Glutamate Release from Rat Cerebrocortical Synaptosomes through GABA A Receptor Activation

The impact of UV radiation on O-7 Actinomycete in producing bioactive compounds in numerous development circumstances

Actinomycetes have been recognized as an origin of many secondary metabolites, antibiotics and energetic parts that influence microbial development. Mediated mutations utilizing UV in follow for the breeding of organisms. The target of this examine is to analyses the influence of UV radiation on the (O-7) Actinomycete isolate. This was a potential analytical examine of a a number of of actinomycetes. The isolates have been screened for antimicrobial efficacy in opposition to a number of Gram-positive, Gram-negative micro organism, yeast, and fungi. Varied elements resembling UV, temperature, pH, gentle, agitation, fermentation durations and aeration have additionally been boosted for optimum antimicrobial manufacturing.

The isolate (O-7) Actinomycete has been acknowledged as a extremely bioactive producing organism. The isolate was uncovered to numerous wavelengths, instances underneath quite a few development circumstances. It was discovered that 4% focus of glucose as a carbon supply is considerably optimum for the manufacturing of antibiotic for (O-7) UV uncovered pressure, nonetheless, focus of 1% of lactose is considerably optimum for the manufacturing of antibiotic for (O-7) UV uncovered pressure. Yeast extract at a focus of 1% was discovered to be the very best supply of nitrogen for (O-7) UV uncovered, whereas pH 7.

Zero was discovered to be probably the most appropriate for a similar isolate. From the temperature optimization examine, it was noticed that (O-7) uncovered pressure confirmed good development and most antibiotic manufacturing at 28 °C. The soil-isolated organic compounds (O-7) have been efficient in opposition to sure sorts of micro organism and fungi, and the analysis additionally demonstrated that publicity to UV radiation enhanced the manufacturing of those compounds.Elucidating the switch of bioactive compounds between crops is important for understanding plant-plant interactions, growing pure pesticides and understanding their modes of motion. This text is protected by copyright. All rights reserved.

Translocation of metabolites between completely different plant species gives necessary hints in understanding the destiny of bioactive root exudates. Within the current examine, focused and untargeted mass spectrometry-based metabolomics was utilized to elucidate the switch of bioactive compounds between rye and a number of other crops and weed species. Our outcomes demonstrated that benzoxazinoids (BXs) synthesized by rye have been taken up by roots of neighbouring plant species and translocated into their shoots.

GPAT2 Recombinant Protein (Human)

RP060951 100 ug Ask for price

Gpat2 ORF Vector (Rat) (pORF)

ORF067727 1.0 ug DNA
EUR 607.2

GPAT2 ORF Vector (Human) (pORF)

ORF020318 1.0 ug DNA Ask for price

Gpat2 ORF Vector (Mouse) (pORF)

ORF046414 1.0 ug DNA
EUR 607.2

Gpat2 sgRNA CRISPR Lentivector set (Rat)

K6080101 3 x 1.0 ug
EUR 406.8

Gpat2 sgRNA CRISPR Lentivector set (Mouse)

K3673901 3 x 1.0 ug
EUR 406.8

GPAT2 sgRNA CRISPR Lentivector set (Human)

K2772901 3 x 1.0 ug
EUR 406.8

GPAT2 3'UTR GFP Stable Cell Line

TU059103 1.0 ml
EUR 2799.6

Gpat2 3'UTR GFP Stable Cell Line

TU255284 1.0 ml Ask for price

Gpat2 3'UTR GFP Stable Cell Line

TU158926 1.0 ml Ask for price

GPAT2 Protein Vector (Rat) (pPM-C-HA)

PV270908 500 ng
EUR 1399.2

GPAT2 Protein Vector (Rat) (pPB-C-His)

PV270906 500 ng
EUR 1399.2

GPAT2 Protein Vector (Rat) (pPB-N-His)

PV270907 500 ng
EUR 1399.2

GPAT2 Protein Vector (Rat) (pPM-C-His)

PV270909 500 ng
EUR 1399.2

GPAT2 Protein Vector (Human) (pPM-C-HA)

PV081271 500 ng Ask for price

GPAT2 Protein Vector (Mouse) (pPM-C-HA)

PV185656 500 ng
EUR 1278

GPAT2 Protein Vector (Human) (pPB-C-His)

PV081269 500 ng Ask for price

GPAT2 Protein Vector (Human) (pPB-N-His)

PV081270 500 ng Ask for price

GPAT2 Protein Vector (Human) (pPM-C-His)

PV081272 500 ng Ask for price

GPAT2 Protein Vector (Mouse) (pPB-C-His)

PV185654 500 ng
EUR 1278

GPAT2 Protein Vector (Mouse) (pPB-N-His)

PV185655 500 ng
EUR 1278

GPAT2 Protein Vector (Mouse) (pPM-C-His)

PV185657 500 ng
EUR 1278

GPAT2 3'UTR Luciferase Stable Cell Line

TU009103 1.0 ml
EUR 2799.6

Gpat2 3'UTR Luciferase Stable Cell Line

TU108926 1.0 ml Ask for price

Gpat2 3'UTR Luciferase Stable Cell Line

TU205284 1.0 ml Ask for price

Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6080102 1.0 ug DNA
EUR 184.8

Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6080103 1.0 ug DNA
EUR 184.8

Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6080104 1.0 ug DNA
EUR 184.8

Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3673902 1.0 ug DNA
EUR 184.8

Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3673903 1.0 ug DNA
EUR 184.8

Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3673904 1.0 ug DNA
EUR 184.8

GPAT2 sgRNA CRISPR Lentivector (Human) (Target 1)

K2772902 1.0 ug DNA
EUR 184.8

GPAT2 sgRNA CRISPR Lentivector (Human) (Target 2)

K2772903 1.0 ug DNA
EUR 184.8

GPAT2 sgRNA CRISPR Lentivector (Human) (Target 3)

K2772904 1.0 ug DNA
EUR 184.8

GPAT1 Antibody

4613-002mg 0.02 mg
EUR 206.18
Description: GPAT1 Antibody: Glycerol-3-phosphate acyltransferase 1 (GPAT1), one of four known GPAT isoforms, is located on the mitochondrial outer membrane, allowing reciprocal regulation with carnitine palmitoyltransferase-1. It is thought to be critical for the development of hepatic steatosis; steatosis triggered by GPAT1 overexpression leads to hepatic and possibly peripheral insulin resistance. GPAT1 is transcriptionally upregulated by insulin and sterol regulatory element binding protein (SREBP-1) and downregulated by AMP-activated protein kinase. Mice deficient in GPAT1 exhibit decreased triacylglycerol (TAG) in cardiomyocytes even in high-fat diets, suggesting that GPAT1 contributes significantly to TAG accumulation in heart tissue during lipogenic or high fat diets.

GPAT1 Antibody

4613-01mg 0.1 mg
EUR 523.7
Description: GPAT1 Antibody: Glycerol-3-phosphate acyltransferase 1 (GPAT1), one of four known GPAT isoforms, is located on the mitochondrial outer membrane, allowing reciprocal regulation with carnitine palmitoyltransferase-1. It is thought to be critical for the development of hepatic steatosis; steatosis triggered by GPAT1 overexpression leads to hepatic and possibly peripheral insulin resistance. GPAT1 is transcriptionally upregulated by insulin and sterol regulatory element binding protein (SREBP-1) and downregulated by AMP-activated protein kinase. Mice deficient in GPAT1 exhibit decreased triacylglycerol (TAG) in cardiomyocytes even in high-fat diets, suggesting that GPAT1 contributes significantly to TAG accumulation in heart tissue during lipogenic or high fat diets.

GPAT1 Antibody

24687-100ul 100ul
EUR 468

GPAT4 Antibody

DF14685 100ul
EUR 420

Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6080105 3 x 1.0 ug
EUR 451.2

GPAT-2 Antibody

DF13583 100ul
EUR 420

Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3673905 3 x 1.0 ug
EUR 451.2

GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K2772905 3 x 1.0 ug
EUR 451.2

Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6080106 1.0 ug DNA
EUR 200.4

Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6080107 1.0 ug DNA
EUR 200.4

Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6080108 1.0 ug DNA
EUR 200.4

Polyclonal GPAT1 Antibody

AMM05175G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPAT1 . This antibody is tested and proven to work in the following applications:

Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3673906 1.0 ug DNA
EUR 200.4

Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3673907 1.0 ug DNA
EUR 200.4

Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3673908 1.0 ug DNA
EUR 200.4

GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K2772906 1.0 ug DNA
EUR 200.4

GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K2772907 1.0 ug DNA
EUR 200.4

GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K2772908 1.0 ug DNA
EUR 200.4

Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody

20-abx211974
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody

20-abx212042
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Glycerol-3-Phosphate Acyltransferase 4 (GPAT4) Antibody

20-abx212043
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Glycerol-3-Phosphate Acyltransferase 3 (GPAT3) Antibody

20-abx329242
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

GPATCH8 Antibody

45984-100ul 100ul
EUR 302.4

GPATCH8 Antibody

45984-50ul 50ul
EUR 224.4

GPATCH8 Antibody

ABD9522 100 ug
EUR 525.6

GPATCH8 Antibody

DF9522 200ul
EUR 420

GPATCH2L Antibody

DF16064 100ul
EUR 420

anti- GPATCH2 antibody

FNab03575 100µg
EUR 658.5
Description: Antibody raised against GPATCH2

anti- GPATCH4 antibody

FNab03576 100µg
EUR 702
Description: Antibody raised against GPATCH4

GPATCH2 Polyclonal Antibody

29987-100ul 100ul
EUR 302.4

GPATCH2 Polyclonal Antibody

29987-50ul 50ul
EUR 224.4

GPATCH8 Conjugated Antibody

C45984 100ul
EUR 476.4

GPATCH2 Polyclonal Conjugated Antibody

C29987 100ul
EUR 476.4

SURP And G-Patch Domain Containing 2 (SUGP2) Antibody

20-abx324076
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

SURP And G-Patch Domain Containing 2 (SFRS14) Antibody

20-abx218818
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

SURP And G-Patch Domain Containing 2 (SFRS14) Antibody

abx237788-100ug 100 ug
EUR 610.8

SURP And G-Patch Domain Containing 2 (SFRS14) Antibody

abx027482-400ul 400 ul
EUR 627.6

SURP And G-Patch Domain Containing 2 (SFRS14) Antibody

abx027482-80l 80 µl
EUR 343.2

G Patch Domain Containing Protein 2 (GPATCH2) Antibody

abx233575-100ug 100 ug
EUR 610.8

G Patch Domain Containing Protein 4 (GPATCH4) Antibody

abx233576-100ug 100 ug
EUR 661.2

G Patch Domain Containing Protein 4 (GPATCH4) Antibody

abx030423-400ul 400 ul
EUR 627.6

G Patch Domain Containing Protein 4 (GPATCH4) Antibody

abx030423-80l 80 µl
EUR 343.2

G Patch Domain-Containing Protein 8 (GPATCH8) Antibody

20-abx215677
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

GPAT1 Peptide

4613P 0.05 mg
EUR 197.7
Description: (CT) GPAT1 peptide

Gpatch4/ Rat Gpatch4 ELISA Kit

ELI-27872r 96 Tests
EUR 1063.2

GPATCH1 siRNA

20-abx918332
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH1 siRNA

20-abx918333
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH2 siRNA

20-abx918336
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH2 siRNA

20-abx918337
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH3 siRNA

20-abx918338
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH3 siRNA

20-abx918339
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH4 siRNA

20-abx918340
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH4 siRNA

20-abx918341
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH8 siRNA

20-abx918342
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH8 siRNA

20-abx918343
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH11 siRNA

20-abx918330
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH11 siRNA

20-abx918331
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH2L siRNA

20-abx918334
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH2L siRNA

20-abx918335
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPATCH2 Rabbit pAb

A17175-100ul 100 ul
EUR 369.6

GPATCH2 Rabbit pAb

A17175-200ul 200 ul
EUR 550.8

GPATCH2 Rabbit pAb

A17175-20ul 20 ul
EUR 219.6

GPATCH2 Rabbit pAb

A17175-50ul 50 ul
EUR 267.6

GPATCH2 ELISA KIT|Human

EF009939 96 Tests
EUR 826.8

GPATCH4 ELISA KIT|Human

EF009940 96 Tests
EUR 826.8

Gpatc2 ORF Vector (Rat) (pORF)

ORF067728 1.0 ug DNA
EUR 607.2

Gpatch1 ORF Vector (Rat) (pORF)

ORF067729 1.0 ug DNA
EUR 607.2

Gpatch4 ORF Vector (Rat) (pORF)

ORF067730 1.0 ug DNA
EUR 607.2

Rat GPATCH4 shRNA Plasmid

20-abx988741
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

GPATC2 ORF Vector (Human) (pORF)

ORF004567 1.0 ug DNA
EUR 114

Gpatc2 3'UTR GFP Stable Cell Line

TU255285 1.0 ml Ask for price

GPATCH4 cloning plasmid

CSB-CL729203HU-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the GPATCH4 gene.

GPATCH2 cloning plasmid

CSB-CL865155HU-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the GPATCH2 gene.

GPATCH4 ORF Vector (Human) (pORF)

ORF004568 1.0 ug DNA
EUR 114

GPATCH1 ORF Vector (Human) (pORF)

ORF020319 1.0 ug DNA Ask for price

GPATCH2 ORF Vector (Human) (pORF)

ORF020320 1.0 ug DNA Ask for price

GPATCH3 ORF Vector (Human) (pORF)

ORF020321 1.0 ug DNA Ask for price

GPATCH8 ORF Vector (Human) (pORF)

ORF020322 1.0 ug DNA
EUR 790.8

Gpatch1 ORF Vector (Mouse) (pORF)

ORF046415 1.0 ug DNA
EUR 607.2

Gpatch2 ORF Vector (Mouse) (pORF)

ORF046416 1.0 ug DNA
EUR 607.2

Gpatch3 ORF Vector (Mouse) (pORF)

ORF046417 1.0 ug DNA
EUR 607.2

Gpatch4 ORF Vector (Mouse) (pORF)

ORF046418 1.0 ug DNA
EUR 607.2

Gpatch4 ORF Vector (Mouse) (pORF)

ORF046419 1.0 ug DNA
EUR 607.2

Gpatch8 ORF Vector (Mouse) (pORF)

ORF046420 1.0 ug DNA
EUR 1886.4

GPATCH1 3'UTR GFP Stable Cell Line

TU059104 1.0 ml
EUR 1672.8

GPATCH2 3'UTR GFP Stable Cell Line

TU059105 1.0 ml
EUR 2799.6

GPATCH3 3'UTR GFP Stable Cell Line

TU059106 1.0 ml
EUR 1672.8

GPATCH4 3'UTR GFP Stable Cell Line

TU059107 1.0 ml
EUR 1672.8

GPATCH8 3'UTR GFP Stable Cell Line

TU059108 1.0 ml
EUR 1825.2

Gpatch1 3'UTR GFP Stable Cell Line

TU255286 1.0 ml Ask for price

Gpatch3 3'UTR GFP Stable Cell Line

TU255287 1.0 ml Ask for price

Gpatch4 3'UTR GFP Stable Cell Line

TU255288 1.0 ml Ask for price

Gpatch1 3'UTR GFP Stable Cell Line

TU158927 1.0 ml Ask for price

Gpatch2 3'UTR GFP Stable Cell Line

TU158928 1.0 ml Ask for price

Gpatch4 3'UTR GFP Stable Cell Line

TU158929 1.0 ml Ask for price

Gpatch8 3'UTR GFP Stable Cell Line

TU158930 1.0 ml Ask for price

Mouse GPATCH8 shRNA Plasmid

20-abx982321
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse GPATCH3 shRNA Plasmid

20-abx982598
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse GPATCH4 shRNA Plasmid

20-abx975701
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse GPATCH1 shRNA Plasmid

20-abx976167
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse GPATCH2 shRNA Plasmid

20-abx976308
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human GPATCH8 shRNA Plasmid

20-abx958020
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human GPATCH1 shRNA Plasmid

20-abx960462
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human GPATCH2 shRNA Plasmid

20-abx960469
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human GPATCH3 shRNA Plasmid

20-abx961854
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

GPATCH8 Blocking Peptide

DF9522-BP 1mg
EUR 234

Moreover, we confirmed that roots of rye crops took up compounds originating from neighbouring crops. Among the many compounds taken up by rye roots, wogonin was detected within the rye shoot, which indicated a root-to-shoot translocation of this compound.

Leave a Reply

Your email address will not be published. Required fields are marked *